Adenine arabinoside in severe thrombocytopenia due to hemorrhagic varicella

Acta Haematol. 1984;72(4):280-4. doi: 10.1159/000206401.

Abstract

An 18-year-old man, admitted because of severe bleeding manifestations due to varicella thrombocytopenia was administered 800 mg/day adenine arabinoside (Ara-A) intravenously for 5 days. 2 days after the start of this treatment the bleeding phenomena became markedly reduced and a progressive increase in the platelet count was noted thereafter. Although a spontaneous improvement is known to occur in patients with varicella thrombocytopenia, the rapid clinical improvement after the Ara-A administration is suggestive for its beneficial effect in the presented patient.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Bone Marrow / ultrastructure
  • Chickenpox / complications*
  • Hemorrhage / etiology*
  • Humans
  • Male
  • Megakaryocytes / ultrastructure
  • Microscopy, Electron
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology
  • Thrombocytopenia / pathology
  • Vidarabine / therapeutic use*

Substances

  • Vidarabine